References
- Boyce JM. Pasturella Species. Principles and Practice of Infectious Diseases5th edn, GL Mandell, JE Bennett, R Dolin. Churchill Livingstone, New York 1995; 2068–70
- Zurlo JJ. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th edn. New York: Churchill Livingstone; 2000. p. 2402–6.
- Smith FR. Pasteurella multocida meningitis. Postgraduate Medical Journal 1980; 56: 250–1
- Kumar A, Devlin HR, Vellend H. Pasteurella multocida Meningitis in an adult: case report and review. Rev Infect Dis 1990; 12: 440–7
- Green BT, Ramsey KM, Nolan PE. Pasteurella multocida meningitis: case report and review of the last 11 y. Scand J Infect Dis 2001; 34: 213–7
- Winner JS, Gentry CA, Machado LJ, Cornea P. Aztreonam treatment of Pasteurella multocida cellulitis and bacteremia. Ann Pharmacother 2003; 37: 392–4
- Duma RJ, Berry AJ, Smith SM, Baggett JW, Swabb EA, Platt TB. Penetration of aztreonam into the cerebrospinal fluid of patients with and without inflamed meninges. Antimicrob Agents Chemother 1984; 26: 730–3
- Modai J, Vittecoq D, Decazes JM, Wolff M, Meulemans A. Penetration of aztreonam into cerebrospinal fluid of patients with bacterial meningitis. Antimicrob Agents Chemother 1986; 29: 281–3
- Petri WA. Antimicrobial Agents. Goodman and Gilman's The Pharmacological Basis of Therapeutics10th edn, JG Hardman. McGraw Hill, New York 2001; 1214
- Brewer NS, Hellinger WC. The Monobactams. Mayo Clin Proc 1991; 66: 1152–7